Oorsprong van het eerstegraads netwerk van Chad E. Beyer
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Promentis Pharmaceuticals, Inc.
Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Kures, Inc.
Kures, Inc. BiotechnologyHealth Technology Kures, Inc. engages in the development of therapeutics for mood disorders. The company is headquartered in Dobbs Ferry, NY.
5
| Subsidiary | Biotechnology | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Chad E. Beyer via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Prolacta Bioscience, Inc.
Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | Pharmaceuticals: Other | Director/Board Member | |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Investment Managers | Private Equity Investor | |
Topaz Pharmaceuticals, Inc.
Topaz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topaz Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets. Its lead investigational product is a topical cream formulation of ivermectin which is under development. The firm provides medicines for the treatment of head lice, acne and infections, as well as vaccines against childhood diseases. The company was founded by Donald P. Beeman and Nicholas U. Spring in 2005 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Miramar Technologies, Inc
Miramar Technologies, Inc Medical SpecialtiesHealth Technology Miramar Technologies, Inc. develops and provides medical devices for dermatologic medical conditions. It specializes in microwave energy positioned to be adopted for dermatologic conditions. The company was founded by Henry A. Plain Jr., Mark E. Deem and Steven Kim in 2006 and is headquartered in Half Moon Bay, CA. | Medical Specialties | Director/Board Member | |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
UCB | Pharmaceuticals: Major | Director/Board Member | |
BIONOMICS LIMITED | Pharmaceuticals: Generic | Chairman Director/Board Member | |
Target Marketing Systems, Inc.
Target Marketing Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Target Marketing Systems, Inc. is a sales training and consulting firm. The private company is based in Atlanta, GA and has subsidiaries in United States. The company was founded by Timothy J. Keane. Timothy J. Keane has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
Booz Allen Hamilton, Inc.
Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | Engineering & Construction | Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Graduate Degree | |
University of Wisconsin | College/University | Undergraduate Degree Doctorate Degree | |
Schwarz Pharma, Inc.
Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCHWARZ PHARMA, Inc. develops and manufactures pharmaceutical products. The company's products include Codimal, Colyte, Edex, Kutrase, Levatol, Robaxin, and Verelan. It was founded in 2003 and is headquartered in Mequon, WI. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
University of Hamburg | College/University | Undergraduate Degree | |
Heinrich-Heine-Universität Düsseldorf | College/University | Corporate Officer/Principal | |
INTELGENX TECHNOLOGIES CORP. | Pharmaceuticals: Major | Director/Board Member | |
Fidelity Information Services LLC
Fidelity Information Services LLC Packaged SoftwareTechnology Services Fidelity Information Services LLC provides processing systems solutions for financial institutions. It offers software, services, consulting and outsourcing solutions focused on retail and institutional banking, payments, asset and wealth management, risk and compliance, trade enablement, transaction processing and record-keeping. The firm also provides online bill pay, government payments, credit and debit payment cards, merchant-issued and network-branded prepaid cards. The company was founded in 1968 and is headquartered in Jacksonville, FL. | Packaged Software | Corporate Officer/Principal | |
First Business Bank (Madison, Wisconsin)
First Business Bank (Madison, Wisconsin) Regional BanksFinance First Business Bank of Madison offers a line of financial services for businesses and business owners, including commercial lending, treasury management, private banking, retirement plans, investment management services, trust services, asset based lending and equipment finance and leasing. The company was founded by Jerry Smith in March 1990 and is headquartered in Madison, WI. | Regional Banks | Director/Board Member | |
Society For Neuroscience
Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services The Society for Neuroscience is an organization with over 36,000 members in more than 95 countries. The non-profit company is based in Washington. The organization also engages in science advocacy and public policy, including an annual Capitol Hill Day, and has various public outreach efforts, such as the interactive collection of public-facing resources on BrainFacts.org. It was founded in 1969 and offers year-round programming, including the publication of two scientific journals, professional development resources, and career training through Neuronline. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
International Association for the Study of Pain
International Association for the Study of Pain Miscellaneous Commercial ServicesCommercial Services International Association for the Study of Pain operates as a professional forum for science, practice, and education in the field of pain. It brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain. The company was founded in 1973 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Yale School of Medicine | College/University | Doctorate Degree | |
Black Horse Investments GmbH
Black Horse Investments GmbH Financial ConglomeratesFinance Black Horse Investments GmbH provides investment services. The firm's investment operations focus on pharmaceutical businesses and property development activities. Its focus areas encompass asset management, project management, and business development and financing. The company is headquartered in Duesseldorf, Germany. | Financial Conglomerates | Chief Executive Officer | |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Yale Graduate School of Arts & Sciences | College/University | Doctorate Degree | |
Akceli, Inc.
Akceli, Inc. Drugstore ChainsRetail Trade Akceli, Inc. operates pharmacies and drug stores. The private company is based in Cambridge, MA. The company was founded by David Chao. | Drugstore Chains | Corporate Officer/Principal | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Studentreasures Acquisition LLC
Studentreasures Acquisition LLC Publishing: Books/MagazinesConsumer Services Studentreasures Acquisition LLC publishes books. It provides a writing activity for teachers and schools. The company is headquartered in Topeka, KS. | Publishing: Books/Magazines | Director/Board Member | |
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Founder | |
Perception Neuroscience, Inc.
Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
GABA Therapeutics, Inc.
GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Black Horse Properties GmbH
Black Horse Properties GmbH Real Estate DevelopmentFinance Black Horse Properties GmbH is a German company that buys and sells land, buildings, and apartments. The private company is based in Dusseldorf, Germany. The CEOs are Patrick Schwarz-Schütte, Torsten Schreiber, Michaela Steimel. The company was founded in 2014. | Real Estate Development | Chief Executive Officer | |
Keane Consultants | President | ||
Gilgamesh Pharmaceuticals, Inc.
Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder Founder | |
DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
AVACEN, Inc.
AVACEN, Inc. Medical SpecialtiesHealth Technology Avacen, Inc. provides non-invasive medical device that provides temporary relief for arthritis, muscle and joint pain. The company was founded by Thomas G. Muehlbauer and Danielle J Forsgren in 2008 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
IntroSpect Digital Therapeutics, Inc.
IntroSpect Digital Therapeutics, Inc. BiotechnologyHealth Technology IntroSpect Digital Therapeutics, Inc. provides digital therapeutic platform for mental health care and support. The firm is designed to extend the life changing potential of psychedelics-assisted psychotherapy to patients in a scalable way. The company was founded by David Keene, Srinivas G. Rao and Florian Brand and is headquartered in San Diego, CA. | Biotechnology | Founder | |
ATAI LIFE SCIENCES N.V. | Pharmaceuticals: Major | Chief Executive Officer | |
EntheogeniX Biosciences, Inc.
EntheogeniX Biosciences, Inc. BiotechnologyHealth Technology EntheogeniX Biosciences, Inc. is a biotech company located in Wilmington, DE. EntheogeniX Biosciences is dedicated to advancing psychedelic research for the development of better medicines for mental health diseases such as depression, bipolar disorder, and schizophrenia. The joint venture company aims to innovate the mental healthcare system by harnessing the power of artificial intelligence and computational biophysics, along with a data-driven pipeline, to uncover new medicines from desired psychedelics to further help patients. EntheogeniX Biosciences is a partnership between atai life sciences and Cyclica. The company was founded by Naheed Kurji and is currently led by CEO Srinivas G. Rao since 2019. | Biotechnology | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 40 |
Duitsland | 9 |
België | 2 |
Australië | 2 |
Canada | 2 |
Sectoraal
Health Technology | 26 |
Consumer Services | 9 |
Commercial Services | 7 |
Finance | 6 |
Distribution Services | 2 |
Operationeel
Director/Board Member | 94 |
Corporate Officer/Principal | 31 |
Chief Executive Officer | 19 |
Chief Tech/Sci/R&D Officer | 16 |
President | 14 |
Sterkste connecties
Insiders | |
---|---|
Robert Mark Weisskoff | 34 |
Srinivas Rao | 22 |
Errol de Souza | 21 |
Stacey Seltzer | 21 |
Timothy J. Keane | 19 |
Klaus Veitinger | 18 |
Thomas R. Beck | 18 |
Patrick Schwarz-Schütte | 9 |
Daniel Lawton | 5 |
Michael P. Neary | 3 |
Sheldon Garrison | 3 |
Andrew Carry Kruegel | 2 |
Dalibor Sames | 2 |
Nicholas Haft | 1 |
Peter Kalivas | 1 |
- Beurs
- Insiders
- Chad E. Beyer
- Bedrijfsconnecties